Your session is about to expire
← Back to Search
Immunochemical Fecal Occult Blood Test (I-FOBT) Kit for Colorectal Cancer
N/A
Waitlist Available
Led By Clement Gwede, PhD, MPH, RN
Research Sponsored by H. Lee Moffitt Cancer Center and Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months post final enrollment
Awards & highlights
Study Summary
This trial will test the usefulness of new educational materials about colorectal cancer and colorectal screening.
Eligible Conditions
- Colorectal Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months post final enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months post final enrollment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Rate of Test Kit Completion
Secondary outcome measures
Overall Colorectal Cancer Screening (CRCS) With Any Test
Time to Kit Return
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: CARES InterventionExperimental Treatment4 Interventions
Colorectal Cancer Awareness, Research, Education and Screening (CARES). At Baseline Visit, Participants in the CARES intervention will receive: I-FOBT kit, a newly developed DVD and booklet, and a mailed reminder card at two weeks post-intervention to remind them about FOBT testing, and follow-up assessments at 12 months.
Group II: Standard Intervention (SI)Active Control4 Interventions
At Baseline Visit, Participants in the standard intervention (SI) condition will get: I-FOBT kit and "Screen for Life" brochure, a mailed reminder card at two weeks post-intervention to remind them about FOBT testing and follow up assessments at 12 months.
Find a Location
Who is running the clinical trial?
H. Lee Moffitt Cancer Center and Research InstituteLead Sponsor
542 Previous Clinical Trials
134,978 Total Patients Enrolled
Clement Gwede, PhD, MPH, RNPrincipal InvestigatorH. Lee Moffitt Cancer Center and Research Institute
1 Previous Clinical Trials
339 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger